小任班长 发布的文章

微信 for Windows 3.0.0 内测版发布,可以在通讯录中批量管理联系人,把小程序添加到桌面使用。另外修复了一些已知问题。目前还未提供大规模下载。

wechat for Windows 3.0.0

更新日志:

  • 可以在通讯录中批量管理联系人;
  • 优化了小程序在电脑上的体验,现在可以把小程序添加到桌面使用;
  • 修复了—些已知问题。

用户可将微信小程序添加到桌面使用,快速启动。

微信 PC 版 3.0.0 内测版发布:小程序添加到桌面使用,可批量管理联系人

通讯录管理

用户可以进行通讯录管理,比如还支持设置朋友权限,包括聊天、朋友圈、微信运动等,仅聊天。

据腾讯微博官方消息,由于业务调整,腾讯微博将于2020年9月28日晚23时59分停止服务和运营,届时将无法登录。

以下为公告全文:
亲爱的用户:
感谢您使用腾讯微博。由于业务调整,腾讯微博将于2020年9目28日晚23时59分停止服务和运营,届时您将无法登录。
腾讯微博
如有需要,您可在停止服务前,备份您的相关信息。对此给您带来的不便,我们深表歉意。

感谢您多年来的陪伴、理解与支持!您如有任何疑问,请通过页面下方“意见反馈”问询,我们将尽快反馈,谢谢!

腾讯微博团队
2020年9月4日

The Chinese bio-specific immunoglobulin made its first public appearance at the Service Trade Fair

At the 2020 China International Trade in Services Fair held in Beijing from September 5th to 9th, Sinopharm Sinopharm, which was invited to participate in the public health and epidemic prevention special exhibition area, presented two new inactivated vaccines for the new crown. The identity of "Main Coffee" made a stunning debut for the first time and attracted the attention of the audience.

COVID-19 vaccine

   It is understood that the two COVID-19 inactivated vaccines exhibited at the exhibition have now entered the final phase III clinical trials, and are being carried out intensively in the UAE, Bahrain, Peru, Morocco, Argentina and other countries and regions. The enrolled 50,000 people were vaccinated, and the sample population has now covered 115 countries, and progress in all aspects is leading the world. At the same time, China National Biotech has established high-level biosafety production facilities in two biological products research institutes in Beijing and Wuhan, and the total annual production capacity of the two vaccine production workshops can reach 300 million doses.

In addition, China's bio-specific immunoglobulin, which has played an important role in the prevention and control of the epidemic in Hubei and Wuhan, as well as in the emergency treatment of critically ill patients in Beijing Xinfadi, Urumqi, Xinjiang, etc., is also in the service trade fair. Made its first public appearance on In the context of the continuous deterioration of the new crown pneumonia epidemic situation in many countries around the world, China's biotechnology anti-epidemic achievements have attracted attention.

  在9月5日-9日于北京举办的2020年中国国际服务贸易交易会上,受邀在公共卫生防疫专题展区参展的国药集团中国生物,拿出承研的两款新冠灭活疫苗以“主咖”身份首次惊艳亮相,引来全场关注。

新冠灭活疫苗

  据了解,参展的两款新冠灭活疫苗目前均已进入最后的Ⅲ期临床试验阶段,正在阿联酋、巴林、秘鲁、摩洛哥、阿根廷等国家和地区紧锣密鼓地展开。入组接种5万人、样本人群现已覆盖115个国家,各方面进展均全球领先。与此同时,中国生物于北京和武汉两个生物制品研究所分别建设高等级生物安全生产设施,两个疫苗生产车间年产能合计可达3亿剂。

  此外,在疫情防控湖北保卫战、武汉保卫战,以及北京新发地、新疆乌鲁木齐等地突发疫情救治危重患者过程中均发挥了重要作用的中国生物特异性免疫球蛋白也在服贸会上首次公开亮相。在全球多国新冠肺炎疫情形势持续恶化的背景下,中国生物科技抗疫成果备受瞩目。

免责声明
本博客部分内容来自于互联网,不代表作者的观点和立场,如若侵犯到您的权益,请联系[email protected]。我们会在24小时内进行删除。